Growing Market Presence PeakData has demonstrated rapid growth, evidenced by successful Series A funding of over $12 million from prominent investors such as Heal Capital, AlbionVC, and Octopus Ventures, indicating strong investor confidence and market traction.

Innovative Technology The company's development of the AI-powered Healthscape platform enhances data mining and analytics capabilities, providing a competitive edge in targeting healthcare professionals and improving pharmaceutical marketing strategies.

Strategic Expansion With offices and staff across the USA, Germany, UK, Poland, Netherlands, and Switzerland, PeakData is well-positioned to expand its global customer base and tailor solutions to diverse regulatory and market environments.

Top Client Engagement Serving over half of the top 20 pharmaceutical companies highlights PeakData’s strong reputation and potential for new high-value clients seeking advanced customer segmentation and targeting solutions.

Significant Growth Potential With revenue estimates between 1 million and 10 million and innovative SaaS offerings, there are substantial opportunities for upselling and expanding the product suite within existing clients and new prospects seeking data-driven healthcare solutions.